{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:13:51Z","timestamp":1788257631254,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Key Project of Tianjin Science and Technology Bureau Applied Basic Research","award":["No. 23JCZDJC01200"],"award-info":[{"award-number":["No. 23JCZDJC01200"]}]},{"name":"the Independent Research Fund of the Institute of Transplant Medicine at Nankai University","award":["No. NKTM2023004"],"award-info":[{"award-number":["No. NKTM2023004"]}]},{"name":"the Tianjin Key Medical Discipline Construction Project","award":["No. TJYXZDXK-3-006A-1"],"award-info":[{"award-number":["No. TJYXZDXK-3-006A-1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16127-7","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:14:07Z","timestamp":1777857247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic value of tumor-infiltrating lymphocytes and common subtypes in patients with gastroenteropancreatic neuroendocrine neoplasms: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Qiming","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"issue":"2","key":"16127_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000518106","volume":"113","author":"IR Popa Ilie","year":"2023","unstructured":"Popa Ilie IR, Georgescu CE. Immunotherapy in Gastroenteropancreatic Neuroendocrine Neoplasia. Neuroendocrinology. 2023;113(2):262\u201378. https:\/\/doi.org\/10.1159\/000518106.","journal-title":"Neuroendocrinology"},{"issue":"5","key":"16127_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4240\/wjgs.v14.i5.397","volume":"14","author":"QY Que","year":"2022","unstructured":"Que QY, Zhang LC, Bao JQ, Ling SB, Xu X. Role of surgical treatments in high-grade or advanced gastroenteropancreatic neuroendocrine neoplasms. World J Gastrointest Surg. 2022;14(5):397\u2013408. https:\/\/doi.org\/10.4240\/wjgs.v14.i5.397.","journal-title":"World J Gastrointest Surg"},{"issue":"17","key":"16127_CR3","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.3748\/wjg.v28.i17.1751","volume":"28","author":"F Yin","year":"2022","unstructured":"Yin F, Wu ZH, Lai JP. New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. World J Gastroenterol. 2022;28(17):1751\u201367. https:\/\/doi.org\/10.3748\/wjg.v28.i17.1751.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"16127_CR4","doi-asserted-by":"publisher","first-page":"24669","DOI":"10.1038\/s41598-024-75882-4","volume":"14","author":"Z Chen","year":"2024","unstructured":"Chen Z, Lin S, Liang F, et al. The prognostic and therapeutic value of the tumor microenvironment and immune checkpoints in pancreatic neuroendocrine neoplasms. Sci Rep. 2024;14(1):24669. https:\/\/doi.org\/10.1038\/s41598-024-75882-4.","journal-title":"Sci Rep"},{"issue":"8","key":"16127_CR5","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.3390\/jcm10081741","volume":"10","author":"G Centonze","year":"2021","unstructured":"Centonze G, Lagano V, Sabella G, et al. Myeloid and T-Cell Microenvironment Immune Features Identify Two Prognostic Sub-Groups in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms. J Clin Med. 2021;10(8):1741. https:\/\/doi.org\/10.3390\/jcm10081741.","journal-title":"J Clin Med"},{"issue":"2","key":"16127_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.pan.2023.01.009","volume":"23","author":"C Gao","year":"2023","unstructured":"Gao C, Fan Z, Yang J, Shi M, Li Y, Zhan H. Diagnostic role and prognostic value of tumor markers in high-grade gastro-enteropancreatic neuroendocrine neoplasms. Pancreatology. 2023;23(2):204\u201312. https:\/\/doi.org\/10.1016\/j.pan.2023.01.009.","journal-title":"Pancreatology"},{"key":"16127_CR7","doi-asserted-by":"publisher","first-page":"101134","DOI":"10.1016\/j.eclinm.2021.101134","volume":"41","author":"F Li","year":"2021","unstructured":"Li F, Li C, Cai X, et al. The association between CD8\u2009+\u2009tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis. EClinicalMedicine. 2021;41:101134. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101134.","journal-title":"EClinicalMedicine"},{"issue":"7","key":"16127_CR8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S2468-1253(24)00091-8","volume":"9","author":"D Wankhede","year":"2024","unstructured":"Wankhede D, Yuan T, Kloor M, Halama N, Brenner H, Hoffmeister M. Clinical significance of combined tumour-infiltrating lymphocytes and microsatellite instability status in colorectal cancer: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2024;9(7):609\u201319. https:\/\/doi.org\/10.1016\/S2468-1253(24)00091-8.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"16127_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/diseases9020042","volume":"9","author":"N Hiltunen","year":"2021","unstructured":"Hiltunen N, V\u00e4yrynen JP, B\u00f6hm J, Helminen O, CD3+. CD8+, CD4\u2009+\u2009and FOXP3\u2009+\u2009T Cells in the Immune Microenvironment of Small Bowel Neuroendocrine Tumors. Diseases. 2021;9(2):42. https:\/\/doi.org\/10.3390\/diseases9020042.","journal-title":"Diseases"},{"issue":"5","key":"16127_CR10","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/MPA.0000000000001831","volume":"50","author":"M Baretti","year":"2021","unstructured":"Baretti M, Zhu Q, Zahurak M, et al. Prognostic Implications of the Immune Tumor Microenvironment in Patients With Pancreatic and Gastrointestinal Neuroendocrine Tumors. Pancreas. 2021;50(5):719\u201326. https:\/\/doi.org\/10.1097\/MPA.0000000000001831.","journal-title":"Pancreas"},{"issue":"10","key":"16127_CR11","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.3390\/diagnostics12102340","volume":"12","author":"HG Cho","year":"2022","unstructured":"Cho HG, Cho SI, Choi S, et al. Artificial Intelligence-Powered Whole-Slide Image Analyzer Reveals a Distinctive Distribution of Tumor-Infiltrating Lymphocytes in Neuroendocrine Neoplasms. Diagnostics (Basel). 2022;12(10):2340. https:\/\/doi.org\/10.3390\/diagnostics12102340.","journal-title":"Diagnostics (Basel)"},{"key":"16127_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. https:\/\/doi.org\/10.1186\/1745-6215-8-16.","journal-title":"Trials"},{"issue":"3","key":"16127_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388. https:\/\/doi.org\/10.1016\/0197-2456(86)90046-2.","journal-title":"Control Clin Trials"},{"issue":"4","key":"16127_CR14","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088\u2013101.","journal-title":"Biometrics"},{"issue":"7109","key":"16127_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334. https:\/\/doi.org\/10.1136\/bmj.315.7109.629.","journal-title":"BMJ"},{"issue":"3","key":"16127_CR16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1530\/ERC-18-0494","volume":"26","author":"F B\u00f6sch","year":"2019","unstructured":"B\u00f6sch F, Br\u00fcwer K, Altendorf-Hofmann A, et al. Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia. Endocr Relat Cancer. 2019;26(3):293\u2013301. https:\/\/doi.org\/10.1530\/ERC-18-0494.","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"16127_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jamcollsurg.2015.12.008","volume":"222","author":"PR de Reuver","year":"2016","unstructured":"de Reuver PR, Mehta S, Gill P, et al. Immunoregulatory Forkhead Box Protein p3-Positive Lymphocytes Are Associated with Overall Survival in Patients with Pancreatic Neuroendocrine Tumors. J Am Coll Surg. 2016;222(3):281\u20137. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2015.12.008.","journal-title":"J Am Coll Surg"},{"issue":"10","key":"16127_CR18","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1477-2574.2010.00231.x","volume":"12","author":"SC Katz","year":"2010","unstructured":"Katz SC, Donkor C, Glasgow K, et al. T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases. HPB (Oxford). 2010;12(10):674\u201383. https:\/\/doi.org\/10.1111\/j.1477-2574.2010.00231.x.","journal-title":"HPB (Oxford)"},{"issue":"4","key":"16127_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/cjp2.135","volume":"5","author":"M Milione","year":"2019","unstructured":"Milione M, Miceli R, Barretta F, et al. Microenvironment and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms. J Pathol Clin Res. 2019;5(4):217\u201326. https:\/\/doi.org\/10.1002\/cjp2.135.","journal-title":"J Pathol Clin Res"},{"issue":"10","key":"16127_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1530\/ERC-21-0223","volume":"28","author":"V Rosery","year":"2021","unstructured":"Rosery V, Reis H, Savvatakis K, et al. Antitumor immune response is associated with favorable survival in GEP-NEN G3. Endocr Relat Cancer. 2021;28(10):683\u201393. https:\/\/doi.org\/10.1530\/ERC-21-0223.","journal-title":"Endocr Relat Cancer"},{"issue":"14","key":"16127_CR21","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.3748\/wjg.v25.i14.1684","volume":"25","author":"MW Yang","year":"2019","unstructured":"Yang MW, Fu XL, Jiang YS, et al. Clinical significance of programmed death 1\/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas. World J Gastroenterol. 2019;25(14):1684\u201396. https:\/\/doi.org\/10.3748\/wjg.v25.i14.1684.","journal-title":"World J Gastroenterol"},{"key":"16127_CR22","doi-asserted-by":"publisher","first-page":"705378","DOI":"10.3389\/fimmu.2021.705378","volume":"12","author":"XJ Guo","year":"2021","unstructured":"Guo XJ, Lu JC, Zeng HY, et al. CTLA-4 Synergizes With PD1\/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma. Front Immunol. 2021;12:705378. https:\/\/doi.org\/10.3389\/fimmu.2021.705378.","journal-title":"Front Immunol"},{"issue":"11","key":"16127_CR23","doi-asserted-by":"publisher","first-page":"e0242173","DOI":"10.1371\/journal.pone.0242173","volume":"15","author":"B Chen","year":"2020","unstructured":"Chen B, Li H, Liu C, et al. Prognostic value of the common tumour-infiltrating lymphocyte subtypes for patients with non-small cell lung cancer: A meta-analysis. PLoS ONE. 2020;15(11):e0242173. https:\/\/doi.org\/10.1371\/journal.pone.0242173.","journal-title":"PLoS ONE"},{"issue":"11","key":"16127_CR24","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1038\/s41416-020-01065-3","volume":"123","author":"E Kalaw","year":"2020","unstructured":"Kalaw E, Lim M, Kutasovic JR, et al. Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1. Br J Cancer. 2020;123(11):1665\u201372. https:\/\/doi.org\/10.1038\/s41416-020-01065-3.","journal-title":"Br J Cancer"},{"issue":"8","key":"16127_CR25","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1158\/1078-0432.CCR-18-1401","volume":"25","author":"L Cai","year":"2019","unstructured":"Cai L, Michelakos T, Deshpande V, et al. Role of Tumor-Associated Macrophages in the Clinical Course of Pancreatic Neuroendocrine Tumors (PanNETs). Clin Cancer Res. 2019;25(8):2644\u201355. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1401.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"16127_CR26","doi-asserted-by":"publisher","first-page":"e3004","DOI":"10.1038\/cddis.2017.401","volume":"8","author":"E Cavalcanti","year":"2017","unstructured":"Cavalcanti E, Armentano R, Valentini AM, Chieppa M, Caruso ML. Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading. Cell Death Dis. 2017;8(8):e3004. https:\/\/doi.org\/10.1038\/cddis.2017.401.","journal-title":"Cell Death Dis"},{"key":"16127_CR27","doi-asserted-by":"publisher","first-page":"1404974","DOI":"10.3389\/fimmu.2024.1404974","volume":"15","author":"W Wang","year":"2024","unstructured":"Wang W, Ding M, Wang Q, et al. Advances in Foxp3\u2009+\u2009regulatory T cells (Foxp3\u2009+\u2009Treg) and key factors in digestive malignancies. Front Immunol. 2024;15:1404974. https:\/\/doi.org\/10.3389\/fimmu.2024.1404974.","journal-title":"Front Immunol"},{"issue":"3","key":"16127_CR28","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/ijc.30475","volume":"140","author":"H Nagase","year":"2017","unstructured":"Nagase H, Takeoka T, Urakawa S, et al. ICOS+ Foxp3\u2009+\u2009TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori. Int J Cancer. 2017;140(3):686\u201395. https:\/\/doi.org\/10.1002\/ijc.30475.","journal-title":"Int J Cancer"},{"issue":"1","key":"16127_CR29","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1186\/s12967-023-04589-3","volume":"21","author":"X He","year":"2023","unstructured":"He X, Peng Y, He G, et al. Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer. J Transl Med. 2023;21(1):717. https:\/\/doi.org\/10.1186\/s12967-023-04589-3.","journal-title":"J Transl Med"},{"issue":"19","key":"16127_CR30","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1158\/1078-0432.CCR-18-0205","volume":"24","author":"T Kato","year":"2018","unstructured":"Kato T, Noma K, Ohara T, et al. Cancer-Associated Fibroblasts Affect Intratumoral CD8\u2009+\u2009and FoxP3\u2009+\u2009T Cells Via IL6 in the Tumor Microenvironment. Clin Cancer Res. 2018;24(19):4820\u201333. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0205.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"16127_CR31","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1007\/s10120-019-00974-4","volume":"22","author":"JY Kim","year":"2019","unstructured":"Kim JY, Kim WG, Kwon CH, Park DY. Differences in immune contextures among different molecular subtypes of gastric cancer and their prognostic impact. Gastric Cancer. 2019;22(6):1164\u201375. https:\/\/doi.org\/10.1007\/s10120-019-00974-4.","journal-title":"Gastric Cancer"},{"issue":"11","key":"16127_CR32","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1007\/s00535-025-02286-0","volume":"60","author":"H Konishi","year":"2025","unstructured":"Konishi H, Urabe Y, Hatsushika Y, et al. Investigating tumor-infiltrating lymphocytes as predictors of lymph node metastasis in deep submucosal invasive esophageal squamous cell carcinoma: a retrospective cross-sectional study. J Gastroenterol. 2025;60(11):1362\u201371. https:\/\/doi.org\/10.1007\/s00535-025-02286-0.","journal-title":"J Gastroenterol"},{"issue":"5","key":"16127_CR33","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1158\/2326-6066.CIR-18-0661","volume":"7","author":"T Cavalleri","year":"2019","unstructured":"Cavalleri T, Bianchi P, Basso G, et al. Combined Low Densities of FoxP3\u2009+\u2009and CD3\u2009+\u2009Tumor-Infiltrating Lymphocytes Identify Stage II Colorectal Cancer at High Risk of Progression. Cancer Immunol Res. 2019;7(5):751\u20138. https:\/\/doi.org\/10.1158\/2326-6066.CIR-18-0661.","journal-title":"Cancer Immunol Res"},{"issue":"11","key":"16127_CR34","doi-asserted-by":"publisher","first-page":"e1356148","DOI":"10.1080\/2162402X.2017.1356148","volume":"6","author":"EJ de Ruiter","year":"2017","unstructured":"de Ruiter EJ, Ooft ML, Devriese LA, Willems SM. The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis. Oncoimmunology. 2017;6(11):e1356148. https:\/\/doi.org\/10.1080\/2162402X.2017.1356148.","journal-title":"Oncoimmunology"},{"key":"16127_CR35","doi-asserted-by":"publisher","first-page":"1476365","DOI":"10.3389\/fimmu.2024.1476365","volume":"15","author":"Q Yan","year":"2024","unstructured":"Yan Q, Li S, He L, Chen N. Prognostic implications of tumor-infiltrating lymphocytes in non-small cell lung cancer: a systematic review and meta-analysis. Front Immunol. 2024;15:1476365. https:\/\/doi.org\/10.3389\/fimmu.2024.1476365.","journal-title":"Front Immunol"},{"issue":"2","key":"16127_CR36","doi-asserted-by":"publisher","first-page":"188311","DOI":"10.1016\/j.bbcan.2019.188311","volume":"1872","author":"WH Zhang","year":"2019","unstructured":"Zhang WH, Wang WQ, Gao HL, Yu XJ, Liu L. The tumor immune microenvironment in gastroenteropancreatic neuroendocrine neoplasms. Biochim Biophys Acta Rev Cancer. 2019;1872(2):188311. https:\/\/doi.org\/10.1016\/j.bbcan.2019.188311.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"2","key":"16127_CR37","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1210\/er.2018-00160","volume":"40","author":"A Mafficini","year":"2019","unstructured":"Mafficini A, Scarpa A. Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms. Endocr Rev. 2019;40(2):506\u201336. https:\/\/doi.org\/10.1210\/er.2018-00160.","journal-title":"Endocr Rev"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16127-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16127-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16127-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:34:18Z","timestamp":1782873258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16127-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16127"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16127-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"14 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"793"}}